Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Q Chip scaling up cGMP production using new funding

15-Sep-2010 - Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.

Sanofi files sBLA with FDA for intradermal influenza vaccine

14-Sep-2010 - Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.


GSK taps Lonza for bio plant knowledge; sells R&D site to Galapagos

08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.

Actavis looks to enter biosimilars through acquisition

08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.

Cipla looking at 25% Cipla Medpro investment

07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.

Colorcon adds Turkey coating lab to tap regional markets

06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.

NanGenex adds bench-top, pilot nano API production tech

01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.

Genzyme rejects Sanofi’s $18.5bn bid; IPT looks at biotech’s turbulent 18-months

31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”

Spenser highlights chitosan advantages for XR delivery

31-Aug-2010 - Laboratory study shows succinyl-chitosan extended-release (XR) excipient could outperform commercially-available delivery technologies, says Spenser Pharmaceuticals.

Tech could allow more drugs to be delivered transdermally

26-Aug-2010 - Transdermal delivery of a broader range of therapeutics could be possible using microdevice fabrication technology Vyteris inked a deal to access.

News in brief

Biologics market worth $158bn by 2015, new report

19-Aug-2010 - Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.

Scolr cuts losses on reduced R&D spending, Q2 revs down

16-Aug-2010 - Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.

Elan halts EDT sale, again; AD drug into Ph III

11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”

Vectura licenses dry powder tech to GSK

09-Aug-2010 - Respiratory formulations specialist Vectura has licensed two dry-formulation technologies to GSK, further strengthening its position in the $25bn (€19bn) asthma and COPD market.

J&J unit licenses Depomed drug delivery technology

09-Aug-2010 - A Johnson & Johnson (J&J) unit has licensed a gastric retentive drug delivery technology from Depomed for use in a combination therapy.

Penwest Q2 revs up, but job cuts likely

05-Aug-2010 - Penwest Pharmaceuticals raises guidance citing Opana ER royalties, deals and patent settlements as Q2 highlights; but warns that job cuts likely under cost cutting plan.

Industry view

Regulatory expert insight: Business Processing Outsourcing

04-Aug-2010 - In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how...

FDA guidance aims to cut residual drug in delivery patches

03-Aug-2010 - FDA draft guidance published this week recommends manufacturers of drug delivery patches adopt QbD to minimise the amount of excess residual drug.

Mylan plans €67m solid-dose packaging plant in Hungary

28-Jul-2010 - Mylan hopes new solid-dose packaging plant in Hungary will help it increase market share in Eastern Europe.

Group claims Irish COE would create 4,800 jobs

20-Jul-2010 - A group of Irish drug firms and banks plan to set up a “global pharmaceutical centre of excellence” (COE) that they believe will create 4,800 research, development and manufacturing jobs.

Merck Millipore launched after $7bn takover

19-Jul-2010 - Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.

Novel drug delivery capsule receives US and EU patent

15-Jul-2010 - Encap has announced its DuoCap capsule delivery system has been granted US and European patents that strengthen the firm’s portfolio in the delivery of pharmaceutical active agents that require controlled...

Eurofarma expands capacity with Laborátorios Gautier

08-Jul-2010 - Brazilian generics manufacturer Eurofarma has acquired Uruguay counterpart Laboratorios Gautier, further expanding its reach across Latin America.

BASF Pharma formed to simplify ops

06-Jul-2010 - Chemicals manufacturer BASF reorganises Swiss business to cut active pharmaceutical ingredient (API) manufacturing site complexity and simplify process operations.

Merck & Co hopes for big win in South Africa

24-Jun-2010 - US drugmaker Merck & Co’s new deal with Adcock Ingram proves the FIFA football World Cup isn’t the only thing attracting people to South Africa this summer.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...